公开(公告)号：US20170258841A1

公开(公告)日：2017-09-14

申请号：US15448050

申请日：2017-03-02

Applicant: Gwo Xi Stem Cell Applied Technology Co., Ltd.

Inventor： Tsung-Ming LEE ,  Ming-Hsi CHUANG ,  Chun-Hung CHEN ,  Po-Cheng LIN ,  Chia-Hsin Lee

IPC: A61K35/28 ,  A61K9/00 ,  A61K31/5377 ,  A61K33/00 ,  A61K31/404

CPC classification number: A61K35/28 ,  A61K9/0019 ,  A61K31/404 ,  A61K31/5377 ,  A61K33/00 ,  A61K2300/00

Abstract: This invention provides a pharmaceutical compositions for treating arrhythmia. The pharmaceutical compositions comprise stem cells, pretreated with n-butylidenephthalide (BP).

公开(公告)号：US20170296586A1

公开(公告)日：2017-10-19

申请号：US15478698

申请日：2017-04-04

Applicant: Gwo Xi Stem Cell Applied Technology Co., Ltd.

Inventor： Sheng-Tzung TSAI ,  Ming-Hsi CHUANG ,  Po-Cheng LIN ,  Pi-Chun HUANG

IPC: A61K35/28

CPC classification number: A61K35/28

Abstract: The present invention provides a pharmaceutical composition to treat cerebral atrophy associated disease. Said pharmaceutical composition comprising adipose-derived stem cells, can reverse the function of excitatory synapses in dementia patients and improve the function of memory storage area in brain.